Camp4 Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Camp4 Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $9.83. The average 1-year stock price forecast is 145.14% higher than the current stock price, while the lowest is $6.00 (+49.63%) and the highest is $15 (+274.06%).

Price Target: $9.83 (+145.14%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$6.00	$9.83	$8.50	$15
Change	+49.63%	+145.14%	+111.97%	+274.06%

Analyst Ratings

The average analyst rating for Camp4 Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	4	4	5	5	5	5
Buy	1	1	2	2	2	2
Hold	1	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $15	Buy	Reiterates	$15	+274.06%	Sep 29, 2026
Keay Nakae Chardan Capital	Chardan Capital	Buy Reiterates $6.5 → $6	Buy	Reiterates	$6.5 → $6	+49.63%	Sep 29, 2026
Myles Minter William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Sep 29, 2026
Yun Zhong Wedbush	Wedbush	Buy Maintains $8	Buy	Maintains	$8	+99.50%	Sep 29, 2026
Steven Seedhouse Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $7	Buy	Maintains	$7	+74.56%	Aug 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

7.27M

from 3.50M

107.95%

from 3.50M

Revenue Next Year

6.08M

from 7.27M

-16.37%

from 7.27M

EPS This Year

-1.04

from -1.65

EPS Next Year

-0.79

from -1.04

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	350.00K	652.00K	3.50M	7.27M
Revenue Growth	-	-	86.29%	436.50%	107.95%
Operating Income	-45.00M	-51.88M	-53.09M	-52.06M	-60.82M
Net Income	-44.19M	-49.29M	-51.79M	-80.40M	-74.39M
EPS	-	-	-	-1.65	-1.04
Free Cash Flow	-	-	-	-29.83M	-51.00M
No. Analysts	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	10.3M
Avg	7.3M
Low	3.1M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	194.5%
Avg	108.0%
Low	-12.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.71
Avg	-1.04
Low	-1.27

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-